Literature DB >> 9406002

The American Urological Association Symptom Index: early postoperative evaluation of irritative and obstructive symptoms due to benign prostatic hyperplasia.

O Ichiyanagi1, M Ishigooka, T Hashimoto, S Hayani, Y Suzuki, T Nakada.   

Abstract

In order to evaluate the acute effects of two different treatments on changes in the American Urological Association symptom score, we divided 23 men with benign prostatic hyperplasia into 2 groups. Group 1 (n = 16) and group 2 (n = 7) were treated with transurethral resection of the prostate and visual laser ablation of the prostate, respectively. Twice before and about 1 week after surgery, patients completed the AUA symptom questionnaire and underwent urodynamic evaluation. The symptom indexes were subcategorized as obstructive and irritative symptoms. All symptom scores were identical in groups 1 and 2 preoperatively. Postoperatively, significant improvement was found in obstructive scores, the total score, maximum and average flow rates only in group 1. This outcome is probably the reflection of an essential dissmilarity in both therapies. Clinically, the obstructive subscore appears reactive to changes in obstruction and seems meaningful in follow-up even in the early postoperative days.

Entities:  

Mesh:

Year:  1997        PMID: 9406002     DOI: 10.1007/bf02551111

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  14 in total

1.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

2.  The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume.

Authors:  J L Bosch; W C Hop; W J Kirkels; F H Schröder
Journal:  Br J Urol       Date:  1995-05

3.  Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy.

Authors:  J E Wennberg; N Roos; L Sola; A Schori; R Jaffe
Journal:  JAMA       Date:  1987-02-20       Impact factor: 56.272

4.  Laser prostatectomy performed with a right angle firing neodymium:YAG laser fiber at 40 watts power setting.

Authors:  J N Kabalin
Journal:  J Urol       Date:  1993-07       Impact factor: 7.450

5.  The correlation of multichannel urodynamic pressure-flow studies and American Urological Association symptom index in the evaluation of benign prostatic hyperplasia.

Authors:  D S Ko; H N Fenster; K Chambers; L D Sullivan; M Jens; S L Goldenberg
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450

6.  Transurethral ultrasound-guided laser-induced prostatectomy: National Human Cooperative Study results.

Authors:  D L McCullough; R A Roth; R K Babayan; J O Gordon; J H Reese; E D Crawford; H A Fuselier; J A Smith; R J Murchison; K W Kaye
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

7.  International prostate symptom score and quality of life assessment versus urodynamic parameters in men with benign prostatic hyperplasia symptoms.

Authors:  G E van Venrooij; T A Boon; R P de Gier
Journal:  J Urol       Date:  1995-05       Impact factor: 7.450

8.  Definition of prostatic urethral obstruction.

Authors:  J Nordling
Journal:  Urol Res       Date:  1994

9.  Treatment of benign prostatic hyperplasia by transurethral ultrasound-guided laser-induced prostatectomy (TULIP): effects on urodynamic parameters and symptoms.

Authors:  J L Bosch; J Groen; F H Schröder
Journal:  Urology       Date:  1994-10       Impact factor: 2.649

10.  Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction.

Authors:  M B Chancellor; D A Rivas; F X Keeley; M A Lotfi; L G Gomella
Journal:  Br J Urol       Date:  1994-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.